# NRX Pharmaceuticals, Inc.: Form 8-K, filed Aug 17, 2026

- Company: [NRX Pharmaceuticals, Inc.](/companies/nrxp.md) (CIK 1719406)
- Form: 8-K
- Filed: 2026-08-17
- Accepted by EDGAR: Aug 17, 2026, 08:00 ET
- Period: 2026-08-17
- Accession: 0001437749-26-028111
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1719406/000143774926028111/nrxp20260817_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1719406/000143774926028111/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1719406/000143774926028111/nrxp20260817_8k.htm

Filed Aug 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-028111. Last ingested by Listed: Nov 2, 2026, 08:07 ET. No prices; not investment advice.